CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale Chief Legal Officer sold 1,750 shares at $27.11 ($47,443)
- 8-K Event Other events
- 4 Planned sale Chief Legal Officer sold 1,996 shares at $25.00 ($49,900)
- 4 Planned sale Chief Executive Officer sold 12,923 shares at $22.49 ($290,598)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 4,248 shares at $21.36 ($90,758)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 12,930 shares at $23.10 ($298,711)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 1,750 shares at $23.71 ($41,494)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 23 · 442 filings